Cargando…
Proof-of-concept study on improved efficacy of rHuEPO administered as a long-term infusion in rats
BACKGROUND: Human recombinant erythropoietin (rHuEPO) is often used in the treatment of diseases associated with a decreased production of red blood cells (RBC), such as chronic renal failure. rHuEPO is typically administered as an intravenous or subcutaneous (SC) injection every few days. The low m...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550370/ https://www.ncbi.nlm.nih.gov/pubmed/32748255 http://dx.doi.org/10.1007/s43440-020-00150-x |